GW Pharmaceuticals PLC Holding(s) in Company (7084Y)
03 December 2014 - 7:22PM
UK Regulatory
TIDMGWP
RNS Number : 7084Y
GW Pharmaceuticals PLC
03 December 2014
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
------------------------------------------------------------------------------------------
1. Identity of the issuer or the underlying GW Pharmaceuticals plc
issuer
of existing shares to which voting rights
are
attached:
---------------------------------------------------- ------------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
--------------------------------------------------------------------------------- -------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
--------------------------------------------------------------------------------- -------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
--------------------------------------------------------------------------------- -------
An event changing the breakdown of voting rights
--------------------------------------------------------------------------------- -------
Other (please
specify):
------------------ ------------------------------------------------------------- -------
3. Full name of person(s) subject The Capital Group Companies, Inc.
to the
notification obligation:
------------------------------------------ ----------------------------------------------
4. Full name of shareholder(s) Capital Research and Management Company
(if different from 3.):
------------------------------------------ ----------------------------------------------
5. Date of the transaction and date 1 December 2014
on
which the threshold is crossed
or
reached:
------------------------------------------ ----------------------------------------------
6. Date on which issuer notified: 2 December 2014
------------------------------------------ ----------------------------------------------
7. Threshold(s) that is/are crossed Above 11%
or
reached:
------------------------------------------ ----------------------------------------------
8. Notified details:
------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN CODE
--------------- ------------------------------------ -----------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of rights
Shares Voting shares
Rights
--------------- --------------- ------------------- --------- ----------------------- -----------------------------
Direct Direct Indirect Direct Indirect
--------------- ----- ------ ------ ----- ---- --------- ---------- ----------- ------------- --------------
ADRs
(US36197T1034) 2,135,921 25,631,053 26,205,841 11.072%
--------------- --------------- ------------------- --------- ---------- ----------- ------------- --------------
B: Qualifying Financial Instruments
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
be
acquired if the
instrument is
exercised/ converted.
------------------------ -------------- --------------------------- --------------------------- --------------------
n/a
------------------------ -------------- --------------------------- --------------------------- --------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date Conversion rights instrument
instrument period refers to
----------------- ------------- ------------- --------------- --------------------------- -------------------------
n/a Nominal Delta
----------------- ------------- ------------- --------------- --------------------------- ------------ -----------
Total (A+B+C)
------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
-------------------------------------------------------------- --------------------------------------------------------
26,205,841 11.072%
-------------------------------------------------------------- --------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable:
--------------------------------------------------------------------------------
Holdings by Capital Research and Management Company SMALLCAP World Fund,
Inc.
Proxy Voting:
--------------------------------------------------------------------------------
10. Name of the proxy holder:
--------------------------------------------------- ---------------------------
11. Number of voting rights proxy holder will
cease
to hold:
--------------------------------------------------- ---------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
--------------------------------------------------- ---------------------------
13. Additional information:
---------------------------------------- --------------------------------------
14. Contact name: Christopher Aquino
---------------------------------------- --------------------------------------
15. Contact telephone number: 800-421-8511
---------------------------------------- --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAPADEAELFEF
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles